Should the Availability of High-Dose Opioids Be Reduced?

SEPTEMBER 13, 2017
In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses whether the FDA should reduce the availability of high-dose opioids in response to the growing opioid abuse epidemic.



SHARE THIS
0